1. Clinical and economic impact of epoetins in cancer care

   • Monia Marchetti
   • Giovanni Barosi

   Review Article 17 September 2012 Pages: 1029 - 1045

   

2. Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence

   • Dyfrig A. Hughes
   • Dominique Dubois

   Original Research Article 17 September 2012 Pages: 1047 - 1059

   

3. Use and cost of antiretrovirals in France 1995–2000

   • Yves A. Flori
   • Marc le Vaillant

   Original Research Article 17 September 2012 Pages: 1061 - 1070

   

4. Etanercept

   • Katherine A. Lyseng-Williamson
   • Greg L. Plosker

   Adis Drug Evaluation 17 September 2012 Pages: 1071 - 1095